Capital Infusion Avidien Technologies secured a 4 million funding round from BroadOak Capital Partners in early 2022, signaling investor confidence and potential capital to scale manufacturing capabilities and expand sales reach in biotech markets.

Internalized Manufacturing The company now manufactures about 90 percent of its parts in-house after acquiring production equipment in Hudson, MA, reducing reliance on outside suppliers and enabling more responsive customization for liquid handling instruments.

Product Focus With the microPro 300 semi-automated 96-channel pipette featuring wireless iPad mini control, Avidien emphasizes compact, integrated automation solutions—a compelling target for labs seeking streamlined, high-throughput liquid handling.

Early Growth Small employee base (2-10) coupled with recent hires in sales and design suggests an opportunity to expand channel partnerships and market presence through strategic recruitment and partner programs.

Strategic Outreach Potential sales opportunities exist in biotech and pharma labs that require customized component production, rapid prototyping, and scalable liquid handling solutions, especially given the operating model shift post internal manufacturing expansion.